Founded by a rare dad on a mission to make orphan drug clinical trials universally accessible, Jeeva’s software solutions are designed to empower rare disease research by engaging patients through the clinical trial journey.
Connecting patients with rare diseases to clinical trials can be daunting due to their scarcity. Jeeva simplifies this through global virtual recruitment tools, reaching patients from diverse locations to maximize participation in your trials.
Rare disease populations are often spread across wide areas. Jeeva facilitates participation through a remote patient engagement portal and omnichannel communications, reducing travel burdens and enhancing inclusivity.
Rare diseases may have simple genetics (e.g., single-gene disorders) but complex phenotypes. Jeeva streamlines complex data collection with user-friendly interfaces for capturing genetics, laboratory test data, photos or videos, and much more.
Navigating diverse regulatory landscapes for rare diseases is challenging. Jeeva provides built-in compliance features and documentation tools that help ensure your trials seamlessly adhere to varying global regulatory standards.
Keeping patients engaged over the long duration typical of rare disease trials is difficult. Jeeva addresses this with personalized communication and support tools that keep participants informed and motivated throughout the study.
Bringing together specialized experts and resources is often a barrier in rare disease research. Jeeva facilitates collaboration through virtual platforms, enabling instant access to a network of experts and shared resources, fostering efficient study execution.
Jeeva’s platform is highly adaptable, allowing researchers to tailor the software to meet the specific needs of each rare disease trial. This customization supports the unique protocols and methodologies required for these specialized studies, ensuring a perfect fit for your research objectives.
Get your rare disease trial up and running swiftly with Jeeva's streamlined setup process. Our software minimizes the time spent on administrative tasks, enabling you to launch studies faster and focus on what truly matters—advancing treatment options for rare conditions.
Jeeva reduces the risk of data errors by automating data entry and management processes. This automation ensures accurate and reliable data capture, freeing your team from manual errors and allowing for more consistent and dependable study results.
Our platform supports on-the-go data collection, enabling participants to report information conveniently from their own devices, no matter where they are. This flexibility is crucial for reaching dispersed populations and capturing real-time data efficiently and accurately in rare disease research.
Jeeva leverages virtual recruitment tools to connect with a global network of patients, making it easier to find and engage individuals with rare diseases, no matter how geographically dispersed they are.
Absolutely. Jeeva’s platform is designed to be flexible and customizable, allowing researchers to tailor the software to the specific protocols and requirements of each rare disease study.
Jeeva reduces data errors through automated data entry and management processes, which help ensure that the data collected is consistent, accurate, and reliable, minimizing human errors.
Participants can easily report data via Jeeva’s platform using their personal devices, enabling real-time and mobile data collection. This capability is particularly beneficial for rare disease trials with patients in diverse locations.
Jeeva facilitates a quick and efficient study setup, minimizing administrative delays. This means your rare disease trials can be launched within four weeks, allowing researchers to focus their efforts on vital study activities.
Jeeva’s built-in compliance features and comprehensive documentation tools support adherence to varying global regulatory requirements, helping researchers navigate the complex regulatory landscape of rare disease clinical trials confidently and effectively.
There’s no upfront CapEx. Our pricing is usage-based, and partners see ROI by reducing site coordination and compliance overhead.
Indo US Organization for Rare Diseases (indousrare.org) is on a mission to help millions of patients of Indian Diaspora affected by any of the 11,000 known rare diseases everywhere with information and connections to accelerate diagnosis, treatment, research, or financial assistance.
The Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders is a non-profit organization on a mission to accelerate the path to clinical treatments for people with severe rare genetic non-verbal neurodevelopmental disorders by pooling efforts, studies, and data. Founded by an inspiring leader, scientist, and mom of a child with #AngelmanSyndrome, Dr. Terry Jo Bichell.
#5 childrens hospital in the United States serving child healthcare needs in the Washington DC area has a mission to advance pediatric care and research in neuroscience, genetics, developmentaldisorders, cancer, cardiovascular, nephrology, diabetes, and endocrinology.
The Special Fathers Network (SFN) is a unique support group designed by the 21st Century Dads Foundation to support fathers of children with special needs
Indo US Organization for Rare Diseases (indousrare.org) is on a mission to help millions of patients of Indian Diaspora affected by any of the 11,000 known rare diseases everywhere with information and connections to accelerate diagnosis, treatment, research, or financial assistance.
Still Curious If Jeeva Human-Centric Clinical Research Software Is a Good Fit for Your Study?
